Cara Therapeutics Stock News

The shares of Cara Therapeutics Inc (NASDAQ: CARA) increased by over 20% pre-market. This is why it happened.

ST. GALLEN, Switzerland & STAMFORD, Conn.--(BUSINESS WIRE)--Regulatory News: Vifor Pharma and Cara Therapeutics (Nasdaq:CARA) today announced that the U.S. Food and Drug Administration (FDA) has appr

After a record-setting day, the news for these two companies was icing on the cake.

STAMFORD, Conn. and ST. GALLEN, Switzerland, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics (Nasdaq: CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has a

Investors need to pay close attention to Cara Therapeutics (CARA) stock based on the movements in the options market lately.

Cara Therapeutics: 200% Upside Possible With FDA Approval

Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q2 2021 Results - Earnings Call Transcript

Cara (CARA) delivered earnings and revenue surprises of -10.91% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of Cara Therapeutics (NASDAQ:CARA) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 12.96% year over year to ($0.61), whic

Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alle

Cara Therapeutics: PDUFA Ahead Makes Current Drop Attractive

It pays to know what could cause them to move and when.

The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue